CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas

A Weich, RA Werner, AK Buck, PE Hartrampf… - Diagnostics, 2021 - mdpi.com
We aimed to elucidate the diagnostic potential of the CXC motif chemokine receptor 4
(CXCR4)-directed positron emission tomography (PET) tracer 68Ga-Pentixafor in patients
with poorly differentiated neuroendocrine carcinomas (NEC), relative to the established
reference standard 18F-FDG PET/computed tomography (CT). In our database, we
retrospectively identified 11 treatment-naïve patients with histologically proven NEC, who
underwent 18F-FDG and CXCR4-directed PET/CT for staging and therapy planning. The …

[PDF][PDF] CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics 2021, 11, 605

A Weich, RA Werner, AK Buck, PE Hartrampf… - 2021 - pdfs.semanticscholar.org
We aimed to elucidate the diagnostic potential of the CXC motif chemokine receptor 4
(CXCR4)-directed positron emission tomography (PET) tracer 68Ga-Pentixafor in patients
with poorly differentiated neuroendocrine carcinomas (NEC), relative to the established
reference standard 18F-FDG PET/computed tomography (CT). In our database, we
retrospectively identified 11 treatment-naïve patients with histologically proven NEC, who
underwent 18F-FDG and CXCR4-directed PET/CT for staging and therapy planning. The …
以上显示的是最相近的搜索结果。 查看全部搜索结果